Fluidigm (FLDM) Tops Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Fluidigm Announces First Quarter 2019 Financial Results
May 2, 2019 4:05 PM EDTFirst quarter revenue increased 19 percent to $30.1 million
Mass cytometry revenue growth of 110 percent in first quarter
Strong mass cytometry and Imaging Mass Cytometry instrument adoption First complete sample-to-answer solution for deep immune profiling in mass cytometry
SOUTH SAN FRANCISCO, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) today announced financial results for the first quarter ended March 31, 2019.
Financial HighlightsFirst Quarter 2019
... More